Talbot et al. [33], using an ex vivo stimulation protocol with near-physiological doses of insulin and IGF-1, demonstrated that the brain in AD, particularly the hippocampal formation (CA1-CA3, DG) and, to a lesser extent, the cerebellar cortex, exhibited insulin and IGF-1 resistance. Here, IGF1 is linked to Alzheimer disease.